Viewing data from:

CHOLESTYRAMINE LIGHT

ANDA

CHOLESTYRAMINE | A074558 | EPIC PHARMA LLC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 4 NDCs

Highest NADAC/Unit

$0.8034

per ea

Lowest NADAC/Unit

$0.1140

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
24658027095CHOLESTYRAMINE LIGHT PACKET	$0.8034	EA	Generic	—	2026-08-19
42806027095CHOLESTYRAMINE LIGHT PACKET	$0.8034	EA	Generic	—	2026-08-19
24658027197CHOLESTYRAMINE LIGHT POWDER	$0.1140	GM	Generic	—	2026-08-19
42806027193CHOLESTYRAMINE LIGHT POWDER	$0.1140	GM	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$23.03

Highest Price

$30.40

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
24658-0270-95CHOLESTYRAMINE 4GM/5GM (LIGHT) PWDR,PKT	$30.40	FSS	Puracap Laboratories, LLC, dba Blu Pharmaceuticals	12/31/2030
24658-0271-93CHOLESTYRAMINE 4GM/5GM (LIGHT) PWDR	$23.03	FSS	Puracap Laboratories, LLC, dba Blu Pharmaceuticals	12/31/2030

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs2 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

PUROLITE LLCCHOLESTYRAMINE RESIN USP

DMF 73241988

ION EXCHANGE INDIA LTDCHOLESTYRAMINE RESIN USP (INDION 454)

DMF 231712009

PHAEX POLYMERS PRIVATE LTDCHOLESTYRAMINE RESIN USP AS IN

DMF 276072013

DOW CHEMICAL COInactiveCHOLESTYRAMINE USP

DMF 57591985

ROHM AND HAAS COInactiveCHOLESTYRAMINE RESIN, USP-AMBERLITE IRP-276

DMF 65061986

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 4GM RESIN/PACKET

0 patents0 exclusivities▴

POWDER;ORAL | Approved: Aug 15, 1996

No patent or exclusivity listings for this strength.

#002 — EQ 4GM RESIN/SCOOPFUL

0 patents0 exclusivities▾

POWDER;ORAL | Approved: Aug 15, 1996